Nuvalent, Inc. (NUVL)
100.19
-1.10
(-1.09%)
USD |
NASDAQ |
Mar 03, 16:00
100.19
0.00 (0.00%)
After-Hours: 16:14
Nuvalent EPS Diluted (Quarterly) : -1.585 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -2.324 |
| Edgewise Therapeutics, Inc. | -0.4737 |
| Neurocrine Biosciences, Inc. | 1.482 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Kodiak Sciences, Inc. | -1.163 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -118.70M |
| Total Expenses (Quarterly) | 118.70M |
| Enterprise Value | 5.993B |
| Earnings Yield | -5.84% |
| Normalized Earnings Yield | -5.314 |